Sensulin
PrivateLast Round
Series A
Dec 16, 2021
Total Funding Raised
$4.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sensulin is a biopharmaceutical company that is developing a glucose-responsive insulin for type 1 and type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sensulin Comparables
Compare Sensulin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thermalin Diabetes | 81% | |
| Zenomics, Inc. | 76% | |
| Merck & Co., Inc. | 76% | |
Sensulin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 16, 2021 | ||||
| VC Round | May 25, 2018 | ||||
| Grant | Dec 1, 2013 | ||||
| Seed | Feb 1, 2013 | ||||
| Grant | Sep 1, 2009 |
Sensulin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| StartUp Health | Series A |
| Cortado Ventures | Series A |
| National Science Foundation | Grant |
| AngelMD | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 68% MoM, reaching 5.4K.
- Dec 16, 2021
$4M round with participation from StartUp Health and Cortado Ventures.
Sensulin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sensulin's valuation, stock price, and market status.